Ionis Pharmaceuticals Cash on Hand 2012-2025 | IONS

Ionis Pharmaceuticals cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.

Ionis Pharmaceuticals cash on hand for the quarter ending September 30, 2025 was $2.240B, a 9.79% decline year-over-year.
Ionis Pharmaceuticals cash on hand for 2024 was $2.298B, a 1.44% decline from 2023.
Ionis Pharmaceuticals cash on hand for 2023 was $2.331B, a 17.33% increase from 2022.
Ionis Pharmaceuticals cash on hand for 2022 was $1.987B, a 6.06% decline from 2021.

Ionis Pharmaceuticals Annual Cash on Hand (Millions of US $)
2024	$2,298
2023	$2,331
2022	$1,987
2021	$2,115
2020	$1,892
2019	$2,500
2018	$2,084
2017	$1,023
2016	$665
2015	$804
2014	$811
2013	$709
2012	$408
2011	$344

Ionis Pharmaceuticals Quarterly Cash on Hand (Millions of US $)
2025-09-30	$2,240
2025-06-30	$2,290
2025-03-31	$2,145
2024-12-31	$2,298
2024-09-30	$2,483
2024-06-30	$2,079
2024-03-31	$2,206
2023-12-31	$2,331
2023-09-30	$2,236
2023-06-30	$2,385
2023-03-31	$2,347
2022-12-31	$1,987
2022-09-30	$1,982
2022-06-30	$2,022
2022-03-31	$2,052
2021-12-31	$2,115
2021-09-30	$1,987
2021-06-30	$2,059
2021-03-31	$1,820
2020-12-31	$1,892
2020-09-30	$2,329
2020-06-30	$2,349
2020-03-31	$2,384
2019-12-31	$2,500
2019-09-30	$2,221
2019-06-30	$2,262
2019-03-31	$2,254
2018-12-31	$2,084
2018-09-30	$1,959
2018-06-30	$1,980
2018-03-31	$1,035
2017-12-31	$1,023
2017-09-30	$1,011
2017-06-30	$856
2017-03-31	$860
2016-12-31	$665
2016-09-30	$697
2016-06-30	$672
2016-03-31	$724
2015-12-31	$804
2015-09-30	$831
2015-06-30	$816
2015-03-31	$789
2014-12-31	$811
2014-09-30	$639
2014-06-30	$648
2014-03-31	$695
2013-12-31	$709
2013-09-30	$736
2013-06-30	$653
2013-03-31	$417
2012-12-31	$408
2012-09-30	$344
2012-06-30	$336
2012-03-31	$334
2011-12-31	$344
2011-09-30	$365
2011-06-30	$395
2011-03-31	$427

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$12.363B	$0.705B
Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$85.303B	32.40
Zoetis (ZTS)	United States	$54.932B	19.66
Takeda Pharmaceutical (TAK)	Japan	$51.421B	10.49
Daiichi Sankyo, - (DSNKY)	Japan	$39.630B	19.74
BeOne Medicines - (ONC)	Switzerland	$37.087B	196.62
Sandoz Group AG (SDZNY)	Switzerland	$33.939B	0.00
United Therapeutics (UTHR)	United States	$20.018B	17.62
Merck (MKKGY)	Germany	$19.496B	12.02
Shionogi (SGIOY)	Japan	$15.261B	14.02
Neurocrine Biosciences (NBIX)	United States	$13.200B	31.67
Summit Therapeutics (SMMT)	United States	$13.140B	0.00
IPSEN (IPSEY)	France	$13.109B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.394B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.236B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$5.981B	33.47
Crinetics Pharmaceuticals (CRNX)	United States	$5.313B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.216B	20.01
Indivior (INDV)	United States	$4.068B	16.60
Corcept Therapeutics (CORT)	United States	$3.653B	39.47
NewAmsterdam Pharma (NAMS)	Netherlands	$3.589B	0.00
Hypermarcas (HYPMY)	Brazil	$3.047B	20.91
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.984B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.790B	8.90
Ocular Therapeutix (OCUL)	United States	$2.401B	0.00
Dyne Therapeutics (DYN)	United States	$2.386B	0.00
Soleno Therapeutics (SLNO)	United States	$2.282B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.958B	23.20
Harrow (HROW)	United States	$1.774B	108.86
Guardian Pharmacy Services (GRDN)	United States	$1.712B	32.96
Ardelyx (ARDX)	United States	$1.640B	0.00
Oruka Therapeutics (ORKA)	United States	$1.617B	0.00
Enliven Therapeutics (ELVN)	United States	$1.585B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.570B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.441B	7.14
BioCryst Pharmaceuticals (BCRX)	United States	$1.404B	83.25
Evotec AG (EVO)	Germany	$1.282B	0.00
Relay Therapeutics (RLAY)	United States	$1.274B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.248B	0.00
Savara (SVRA)	United States	$1.184B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.051B	0.00
Theravance Biopharma (TBPH)	United States	$1.014B	42.57
Cronos Group (CRON)	Canada	$0.967B	0.00
Xencor (XNCR)	United States	$0.913B	0.00
Nektar Therapeutics (NKTR)	United States	$0.766B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.738B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.732B	17.31
Esperion Therapeutics (ESPR)	United States	$0.727B	0.00
ProKidney (PROK)	United States	$0.689B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.680B	6.07
Bioventus (BVS)	United States	$0.656B	13.44
Lexeo Therapeutics (LXEO)	United States	$0.539B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.506B	0.00
Lyell Immunopharma (LYEL)	United States	$0.505B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.503B	0.00
Organogenesis (ORGO)	United States	$0.481B	0.00
Siga Technologies (SIGA)	United States	$0.471B	6.45
Altimmune (ALT)	United States	$0.442B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.431B	0.00
Nature's Sunshine Products (NATR)	United States	$0.421B	25.07
Aquestive Therapeutics (AQST)	United States	$0.404B	0.00
USANA Health Sciences (USNA)	United States	$0.401B	11.19
Akebia Therapeutics (AKBA)	United States	$0.361B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.310B	0.00
Profound Medical (PROF)	Canada	$0.298B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.284B	0.00
Avalo Therapeutics (AVTX)	United States	$0.279B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.279B	0.00
Relmada Therapeutics (RLMD)	United States	$0.274B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Fractyl Health (GUTS)	United States	$0.262B	0.00
Larimar Therapeutics (LRMR)	United States	$0.259B	0.00
Protara Therapeutics (TARA)	United States	$0.259B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.238B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.223B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.209B	0.00
Galectin Therapeutics (GALT)	United States	$0.196B	0.00
Minerva Neurosciences (NERV)	United States	$0.193B	0.00
Century Therapeutics (IPSC)	United States	$0.190B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
MediWound (MDWD)	Israel	$0.180B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
VAXART, INC (VXRT)	United States	$0.169B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.146B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Context Therapeutics (CNTX)	United States	$0.132B	0.00
Incannex Healthcare (IXHL)	Australia	$0.131B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Avita Medical (RCEL)	United States	$0.119B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.116B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.114B	0.00
Pyxis Oncology (PYXS)	United States	$0.110B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.105B	0.00
Champions Oncology (CSBR)	United States	$0.100B	42.41
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Korro Bio (KRRO)	United States	$0.083B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Gain Therapeutics (GANX)	United States	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.13
PolyPid (PYPD)	Israel	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.067B	0.00
Arch Biopartners (ACHFF)	Canada	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.060B	0.00
ElectroCore (ECOR)	United States	$0.057B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Lite Strategy (LITS)	United States	$0.053B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.048B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.037B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.030B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.020B	0.00
Inotiv (NOTV)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Vyome Holdings (HIND)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00